Bcl-2 small hairpin RNAs enhance radiation-induced apoptosis in A549 cells

Dong-Mei He1, Yuan Zhang, Ge-Xiu Liu

  • 1Institute of Haematology, Medical College of Jinan University, No. 601 West Huangpudadao, Guangzhou 510632, China. thedm@jnu.edu.cn

Insights

Targeting Bcl-2 (B-cell lymphoma 2) with small hairpin RNA (shRNA) enhances radiation-induced apoptosis in A549 lung cancer cells. This approach increases cell death, making cancer cells more susceptible to radiation therapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Bcl-2 protein dys-regulates apoptosis and promotes resistance to cancer therapies.
  • Understanding mechanisms to overcome chemo- and radioresistance is crucial for effective cancer treatment.

Purpose of the Study:

  • To investigate if targeting Bcl-2 with small hairpin RNA (shRNA) sensitizes A549 cells to gamma radiation-induced apoptosis.
  • To evaluate the efficacy of Bcl-2 shRNA in combination with radiation therapy.

Main Methods:

  • A549 cells were transfected with recombinant Bcl-2 shRNA expression vectors.
  • Stable transfectants were selected and Bcl-2 protein expression was confirmed via Western blot.
  • Cell viability was assessed using MTT assays, and apoptosis was analyzed by morphological observation and flow cytometry.

Main Results:

  • Stable transfection with Bcl-2 shRNA significantly reduced Bcl-2 protein levels in A549 cells.
  • Bcl-2 shRNA transfection decreased cell viability and significantly enhanced radiation-induced apoptosis.
  • Control shRNA had no significant impact on cell growth or radiosensitivity.

Conclusions:

  • Small hairpin RNA targeting Bcl-2 effectively downregulates Bcl-2 expression in A549 cells.
  • Inhibiting Bcl-2 with shRNA increases susceptibility to radiation-induced apoptosis, offering a potential strategy to enhance radiotherapy efficacy.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...